H L Robinson|T M Pertmer - JoVE Visualize

Showing results (91-100 of 104) with videos related to

Pageof 11

Sort By:

AIDS Research and Human Retroviruses|February 14, 1998

Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regionsS Lu, R Wyatt, J F Richmond, et al.

Journal of Medical Primatology|September 4, 1999

Neutralizing antibody responses in Africa green monkeys naturally infected with simian immunodeficiency virus (SIVagm)M M Gicheru, M Otsyula, P Spearman, et al.

Cell|October 1, 1979

Heterogeneity of genetic loci in chickens: analysis of endogenous viral and nonviral genes by cleavage of DNA with restriction endonucleasesS H Hughes, F Payvar, D Spector, et al.

Journal of Virology|January 1, 1996

Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeysY Yasutomi, H L Robinson, S Lu, et al.

Journal of Virology|June 8, 2001

Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaquesD C Montefiori, J T Safrit, S L Lydy, et al.

Virology|April 14, 1997

Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boostingJ F Richmond, F Mustafa, S Lu, et al.

Virology|March 3, 1997

HIV-1 Env glycoproteins from two series of primary isolates: replication phenotype and immunogenicityF Mustafa, J F Richmond, R Fernandez-Larsson, et al.

Nature Medicine|July 11, 2000

Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measlesF P Polack, S H Lee, S Permar, et al.

AIDS Research and Human Retroviruses|July 13, 2006

Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adultsM J Mulligan, N D Russell, C Celum, et al.

Molecular Medicine (Cambridge, Mass.)|July 3, 1999

Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primatesM J McCluskie, C L Brazolot Millan, R A Gramzinski, et al.

Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:

Pageof 11

AIDS Research and Human Retroviruses|February 14, 1998

Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regionsS Lu, R Wyatt, J F Richmond, et al.

Journal of Medical Primatology|September 4, 1999

Neutralizing antibody responses in Africa green monkeys naturally infected with simian immunodeficiency virus (SIVagm)M M Gicheru, M Otsyula, P Spearman, et al.

Cell|October 1, 1979

Heterogeneity of genetic loci in chickens: analysis of endogenous viral and nonviral genes by cleavage of DNA with restriction endonucleasesS H Hughes, F Payvar, D Spector, et al.

Journal of Virology|January 1, 1996

Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeysY Yasutomi, H L Robinson, S Lu, et al.

Journal of Virology|June 8, 2001

Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaquesD C Montefiori, J T Safrit, S L Lydy, et al.

Virology|April 14, 1997

Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boostingJ F Richmond, F Mustafa, S Lu, et al.

Virology|March 3, 1997

HIV-1 Env glycoproteins from two series of primary isolates: replication phenotype and immunogenicityF Mustafa, J F Richmond, R Fernandez-Larsson, et al.

Nature Medicine|July 11, 2000

Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measlesF P Polack, S H Lee, S Permar, et al.

AIDS Research and Human Retroviruses|July 13, 2006

Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adultsM J Mulligan, N D Russell, C Celum, et al.

Molecular Medicine (Cambridge, Mass.)|July 3, 1999

Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primatesM J McCluskie, C L Brazolot Millan, R A Gramzinski, et al.

Pageof 11